Kura Oncology Reports Preclinical Data Showing Ability of KO-2806 to Enhance Antitumor Activity ...
– Oral presentation at RAS Summit supports development of next-generation FTI in combination with KRASG12C inhibitors –
Source: eagletribune.com
Stay updated with breaking news from Francis Burrows. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
– Oral presentation at RAS Summit supports development of next-generation FTI in combination with KRASG12C inhibitors –
28.09.2023 - – Oral presentation at RAS Summit supports development of next-generation FTI in combination with KRASG12C inhibitors – – Company to include KRASG12C-mutant NSCLC in combination portion of Phase 1 clinical trial of KO-2806 (FIT-001) – SAN DIEGO, ... Seite 1
HEROIC lifeguards have been commended after saving a woman from drowning at Beale Park.